Medical ablation of endobronchial mucormycosis with Amphotericin-B.

Viswam, Darsana; Gopinathan, V P; Indira, Kumari; Vinod, Shalini; Sasankan, Natasha.
Artículo en Inglés | IMSEAR | ID: sea-94376

Documentos relacionados

  1. An autopsy case of disseminated Cunninghamella bertholletiae infection in an immunocompetent patient: a case report.
  2. [Bronchoscopic intervention therapy for pulmonary mucormycosis with main bronchial occlusion: a case report].
  3. Outcomes after lung resection in renal transplant patients with pulmonary mucormycosis.
  4. Medical ablation of endobronchial mucormycosis with Amphotericin-B.
  5. Mucormycosis.
  6. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
  7. Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.
  8. Our 2014 approach to mucormycosis.
  9. Cutaneous Mucormycosis by Saksenaea vasiformis: An Unusual Case Report and Review of Literature.
  10. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.